Clinical repercussions of statin use during pregnancy: a review of the literature

Rev Bras Ginecol Obstet. 2025 Mar 17:47:e-rbgo2. doi: 10.61622/rbgo/2025rbgo2. eCollection 2025.

Abstract

Statins are the most widely used pharmacological class for treating hyperlipidemia, although they are contraindicated during pregnancy. This study aims to demonstrate the clinical effects of statins in pregnant women through an interactive review. Fifteen original articles were selected, in English or Portuguese, within of five years. Statins have not been associated with the development of fetal malformations and their use may be useful in preventing unfavorable cardiovascular outcomes, with the potential to reduce oxidative stress and angiogenic dysfunction. However, the use of statins to prevent pre-eclampsia in humans has not been properly clarified and further studies are needed. Pravastatin is considered safer than statins for use during pregnancy.

Keywords: Antihypertensive agents; Hydroxymethylglutaryl-CoA reductase inhibitors; Pravastatin; Pre-eclampsia; Pregnancy; Pregnant woman.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Pregnancy
  • Pregnancy Complications* / drug therapy
  • Pregnancy Complications* / prevention & control

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors